NEW YORK (GenomeWeb) – LGC today announced it has reached a deal to acquire Biosearch Technologies for an undisclosed amount. 

Based in Petaluma, Calif., Biosearch manufactures and supplies custom oligonucleotides and associated reagents to the medical diagnostics, research, and applied markets. Its products are used in molecular diagnostics and the applied and research sectors of the genomics space, LGC said, adding that Biosearch works with the world's top 12 molecular diagnostics firms. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.